- Home
- LEG vs TNGX Comparison
LEG vs TNGX Comparison
Compare LEG & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEG
- TNGX
- Stock Information
- Founded
- LEG 1883
- TNGX 2014
- Country
- LEG United States
- TNGX United States
- Employees
- LEG N/A
- TNGX N/A
- Industry
- LEG Home Furnishings
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- LEG Consumer Discretionary
- TNGX Health Care
- Exchange
- LEG Nasdaq
- TNGX Nasdaq
- Market Cap
- LEG 1.2B
- TNGX 1.0B
- IPO Year
- LEG N/A
- TNGX N/A
- Fundamental
- Price
- LEG $9.03
- TNGX $8.18
- Analyst Decision
- LEG Hold
- TNGX Strong Buy
- Analyst Count
- LEG 4
- TNGX 6
- Target Price
- LEG $10.00
- TNGX $10.80
- AVG Volume (30 Days)
- LEG 1.8M
- TNGX 4.5M
- Earning Date
- LEG 10-27-2025
- TNGX 11-04-2025
- Dividend Yield
- LEG 2.22%
- TNGX N/A
- EPS Growth
- LEG N/A
- TNGX N/A
- EPS
- LEG 1.61
- TNGX N/A
- Revenue
- LEG $4,172,899,999.00
- TNGX $66,501,000.00
- Revenue This Year
- LEG N/A
- TNGX $20.41
- Revenue Next Year
- LEG N/A
- TNGX N/A
- P/E Ratio
- LEG $5.59
- TNGX N/A
- Revenue Growth
- LEG N/A
- TNGX 53.29
- 52 Week Low
- LEG $6.48
- TNGX $1.03
- 52 Week High
- LEG $13.20
- TNGX $9.70
- Technical
- Relative Strength Index (RSI)
- LEG 48.62
- TNGX 52.85
- Support Level
- LEG $8.57
- TNGX $7.49
- Resistance Level
- LEG $9.25
- TNGX $8.74
- Average True Range (ATR)
- LEG 0.37
- TNGX 0.64
- MACD
- LEG -0.02
- TNGX -0.03
- Stochastic Oscillator
- LEG 20.14
- TNGX 59.49
About LEG Leggett & Platt Incorporated
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.